Your account is not claimed yet. You can sign up with ORCID to claim your account.

Junjiang Fu (J Fu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 47

Top Venues

Molecular biology reports

Journal of cellular and molecular medicine

Molecules (Basel, Switzerland)

3 Biotech

Southwest Medical University

Hunan Medical University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Southwest Medical University

China

Professor and Director :: Key Laboratory of Epigenetics and Oncology

Education History

Hunan Medical University

China

MSC

Publications

Junjiang Fu, Saber Imani, Mei-Yi Wu, Ray-Chang Wu
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential. Cancers 15 (19) (2023)
Ting Li, Qi Tan, Chunli Wei, Hui Zou, Xiaoyan Liu, Zhiqiang Mei, Peng Fei Zhang, Jingliang Cheng, Junjiang Fu
Design, Synthesis, and Acute Toxicity Assays for Novel Thymoquinone Derivative TQFL12 in Mice and the Mechanism of Resistance to Toxicity. Molecules (Basel, Switzerland) 28 (13) (2023)
Binghui Song, Jiewen Fu, Jie Qian, Lisha Yang, Jingliang Cheng, Junjiang Fu
Genetic Polymorphism and Population Genetic Structure Analysis of 21 Autosomal STR Loci for a Han-Chinese Population from Luzhou of Southwest China. Genes 14 (7) (2023)
Jiewen Fu, Binghui Song, Jie Qian, Ting He, Hanchun Chen, Jingliang Cheng, Junjiang Fu
Genetic Polymorphism Analysis of 24 Y-STRs in a Han Chinese Population in Luzhou, Southwest China. Genes 14 (10) (2023)
Binghui Song, Jie Qian, Junjiang Fu
Research progress and potential application of microRNA and other non-coding RNAs in forensic medicine. International journal of legal medicine (2023)
Jingliang Cheng, Ting Li, Qi Tan, Jiewen Fu, Lianmei Zhang, Luquan Yang, Baixu Zhou, Lisha Yang, Shangyi Fu, Alora Grace Linehan, Junjiang Fu
Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree. Journal of cellular and molecular medicine (2023)
Jiayue He, Shuguang Liu, Qi Tan, Zhiying Liu, Jiewen Fu, Ting Li, Chunli Wei, Xiaoyan Liu, Zhiqiang Mei, Jingliang Cheng, Kai Wang, Junjiang Fu
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali H El-Far, Soad K Al Jaouni, Xiaotao Li, Junjiang Fu
Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics. Phytotherapy research : PTR 36 (8) (2022)
H Deng, Md Asaduzzaman Khan, Xiaoyan Liu, Junjiang Fu, Z Mei
Identification of SCAR markers for genetic authentication of Dendrobium nobile Lindl. Brazilian journal of biology = Revista brasleira de biologia 82 (2022)
Jiewen Fu, Shuguang Liu, Qi Tan, Zhiying Liu, Jie Qian, Ting Li, Jiaman Du, Binghui Song, Dabing Li, Lianmei Zhang, Jiayue He, Kan Guo, Baixu Zhou, Hanchun Chen, Shangyi Fu, Xiaoyan Liu, Jingliang Cheng, Tao He, Junjiang Fu
Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2. Molecules (Basel, Switzerland) 27 (21) (2022)
Md Asaduzzaman Khan, Meiling Zheng, Jiewen Fu, Mousumi Tania, Jun Li, Junjiang Fu
Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro. BMC cancer 22 (1) (2022)
Jiayue He, Shuguang Liu, Qi Tan, Zhiying Liu, Jiewen Fu, Ting Li, Chunli Wei, Xiaoyan Liu, Zhiqiang Mei, Jingliang Cheng, Kai Wang, Junjiang Fu
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. Molecules (Basel, Switzerland) 27 (24) (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports (2022)
Binghui Song, Shiyi Shen, Shangyi Fu, Junjiang Fu
HSPA6 and its role in cancers and other diseases. Molecular biology reports 49 (11) (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports 50 (3) (2022)
Lisha Yang, Jiewen Fu, Jingliang Cheng, Baixu Zhou, Xiaoyan Liu, Songyot Anuchapreeda, Junjiang Fu
Novel, heterozygous, pathogenic variant (c.4272delA: p.I1426Ffs*2) for the NF1 gene in a large Chinese family with neurofibromatosis type 1. Molecular biology reports (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports 50 (3) (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports 50 (3) (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports (2022)
Jiayue He, Shuguang Liu, Qi Tan, Zhiying Liu, Jiewen Fu, Ting Li, Chunli Wei, Xiaoyan Liu, Zhiqiang Mei, Jingliang Cheng, Kai Wang, Junjiang Fu
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. Molecules (Basel, Switzerland) 27 (24) (2022)
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Molecular biology reports 50 (3) (2022)
Jiayue He, Shuguang Liu, Qi Tan, Zhiying Liu, Jiewen Fu, Ting Li, Chunli Wei, Xiaoyan Liu, Zhiqiang Mei, Jingliang Cheng, Kai Wang, Junjiang Fu
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. Molecules (Basel, Switzerland) 27 (24) (2022)
Chunli Wei, Yun Liu, Xiaoyan Liu, Jingliang Cheng, Jiewen Fu, Xiuli Xiao, Robb E Moses, Xiaotao Li, Junjiang Fu
The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1. Cell death discovery 8 (1) (2022)
Syeda Kubra, Haiyang Zhang, Youwen Si, Xiao Gao, Tianzhen Wang, Linian Pan, Lei Li, Nanzhe Zhong, Junjiang Fu, Bianhong Zhang, Xiaotao Li
REGγ regulates circadian clock by modulating BMAL1 protein stability. Cell death discovery 7 (1) (2021)
Jingliang Cheng, Ju Zhou, Shangyi Fu, Jiewen Fu, Baixu Zhou, Hanchun Chen, Junjiang Fu, Chunli Wei
Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2. Journal of cellular and molecular medicine 25 (8) (2021)
Ju Zhou, Saber Imani, Marzieh Dehghan Shasaltaneh, Shuguang Liu, Tao Lu, Junjiang Fu
PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway. Molecular biology reports (2021)
Jiewen Fu, Shangyi Fu, Shiqiang Yin, Jingliang Cheng, Xiaoyan Liu, Zeming Jin, Tao He, Junjiang Fu
Technical note: multi-alleles at the DYS385ab locus with high frequency in a Han Chinese population from southwestern China. International journal of legal medicine 135 (5) (2021)
Jingliang Cheng, Qi Zhou, Jiewen Fu, Chunli Wei, Lianmei Zhang, Md Shamsuddin Sultan Khan, Hongbin Lv, Songyot Anuchapreeda, Junjiang Fu
Novel compound heterozygous missense variants (c.G955A and c.A1822C) of CACNA2D4 likely causing autosomal recessive retinitis pigmentosa in a Chinese patient. 3 Biotech 11 (5) (2021)
Chunli Wei, Hui Zou, Ting Xiao, Xiaoyan Liu, Qianqian Wang, Jingliang Cheng, Shangyi Fu, Jiangzhou Peng, Xin Xie, Junjiang Fu
TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway. Journal of cellular and molecular medicine 25 (21) (2021)
Jingliang Cheng, Binghui Song, Jiewen Fu, Xiaoli Zheng, Tao He, Junjiang Fu
Genetic polymorphism of 19 autosomal STR loci in the Yi ethnic minority of Liangshan Yi autonomous prefecture from Sichuan province in China. Scientific reports 11 (1) (2021)
Jiewen Fu, Jingliang Cheng, Chunli Wei, Md Asaduzzaman Khan, Zeming Jin, Junjiang Fu
Assessing 23 Y-STR loci mutation rates in Chinese Han father-son pairs from southwestern China. Molecular biology reports 47 (10) (2020)
Xiaoyan Liu, Jingliang Cheng, Zhiqiang Mei, Chunli Wei, Md Asaduzzaman Khan, Jiangzhou Peng, Junjiang Fu
SCAR marker for identification and discrimination of specific medicinal Lycium chinense Miller from Lycium species from ramp-PCR RAPD fragments. 3 Biotech 10 (8) (2020)
Junjiang Fu, Li Liao, Kyathegowdanadoddi Srinivasa Balaji, Chunli Wei, Jaehoon Kim, Jiangzhou Peng
Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis. Oncogene 40 (3) (2020)
Jiewen Fu, Baixu Zhou, Lianmei Zhang, Kyathegowdanadoddi Srinivasa Balaji, Chunli Wei, Xiaoyan Liu, Hanchun Chen, Jiangzhou Peng, Junjiang Fu
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Molecular biology reports 47 (6) (2020)
Jiewen Fu, Shiyi Shen, Jingliang Cheng, Hongbin Lv, Junjiang Fu
A case of Usher syndrome type IIA caused by a rare USH2A homozygous frameshift variant with maternal uniparental disomy (UPD) in a Chinese family. Journal of cellular and molecular medicine 24 (14) (2020)
Jingliang Cheng, Jiangzhou Peng, Jiewen Fu, Md Asaduzzaman Khan, Pingping Tan, Chunli Wei, Xiyun Deng, Hanchun Chen, Junjiang Fu
Identification of a novel germline BRCA2 variant in a Chinese breast cancer family. Journal of cellular and molecular medicine 24 (2) (2019)
Baixu Zhou, Chunli Wei, Md Asaduzzaman Khan, Hanchun Chen, Junjiang Fu
Characterization and molecular cloning of novel isoforms of human spermatogenesis associated gene SPATA3. Molecular biology reports 46 (4) (2019)
Dongsong Nie, Jiewen Fu, Hanchun Chen, Jingliang Cheng, Junjiang Fu
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential. International journal of molecular sciences 20 (4) (2019)
Saber Imani, Jingliang Cheng, Jiewen Fu, Abdolkarim Mobasher-Jannat, Chunli Wei, Saman Mohazzab-Torabi, Khosrow Jadidi, Mohammad Hossein Khosravi, Marzieh Dehghan Shasaltaneh, Lisha Yang, Md Asaduzzaman Khan, Junjiang Fu
Novel splicing variant c. 208+2T>C in BBS5 segregates with Bardet-Biedl syndrome in an Iranian family by targeted exome sequencing. Bioscience reports 39 (3) (2019)
Jingliang Cheng, Jiewen Fu, Qi Zhou, Xiaohong Xiang, Chunli Wei, Lisha Yang, Shangyi Fu, Md Asaduzzaman Khan, Hongbin Lv, Junjiang Fu
A novel splicing mutation in the PRPH2 gene causes autosomal dominant retinitis pigmentosa in a Chinese pedigree. Journal of cellular and molecular medicine 23 (5) (2019)
Chunli Wei, Lisha Yang, Jingliang Cheng, Saber Imani, Shangyi Fu, Hongbin Lv, Yumei Li, Rui Chen, Elaine Lai-Han Leung, Junjiang Fu
A novel homozygous variant of GPR98 causes usher syndrome type IIC in a consanguineous Chinese family by next generation sequencing. BMC medical genetics 19 (1) (2018)
Jiewen Fu, Jingliang Cheng, Xiaoyan Liu, Jun Li, Chunli Wei, Xiaoli Zheng, Tao He, Junjiang Fu
Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing. Molecular biology reports 45 (6) (2018)
Jiewen Fu, Lu Ma, Jingliang Cheng, Lisha Yang, Chunli Wei, Shangyi Fu, Hongbin Lv, Rui Chen, Junjiang Fu
A novel, homozygous nonsense variant of the CDHR1 gene in a Chinese family causes autosomal recessive retinal dystrophy by NGS-based genetic diagnosis. Journal of cellular and molecular medicine 22 (11) (2018)
Jun Li, Md Asaduzzaman Khan, Chunli Wei, Jingliang Cheng, Hanchun Chen, Lisha Yang, Iqra Ijaz, Junjiang Fu
Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1. Molecules (Basel, Switzerland) 22 (12) (2017)
Qiuhong Zuo, Shanshan Cheng, Wenxiang Huang, Muhammad Zeeshan Bhatti, Yanyan Xue, Yuanyuan Zhang, Bianhong Zhang, Lei Li, Lin Wu, Junjiang Fu, Jiwu Chen, Xiaotao Li
REGγ Contributes to Regulation of Hemoglobin and Hemoglobin δ Subunit. Oxidative medicine and cellular longevity 2017 (2017)
Saber Imani, Jingliang Cheng, Abdolkarim Mobasher-Jannat, Chunli Wei, Shangyi Fu, Lisha Yang, Khosrow Jadidi, Mohammad Hossein Khosravi, Saman Mohazzab-Torabi, Marzieh Dehghan Shasaltaneh, Yumei Li, Rui Chen, Junjiang Fu
Identification of a novel RPGRIP1 mutation in an Iranian family with leber congenital amaurosis by exome sequencing. Journal of cellular and molecular medicine 22 (3) (2017)
Qi Zhou, Jingliang Cheng, Weichan Yang, Mousumi Tania, Hui Wang, Md Asaduzzaman Khan, Chengxia Duan, Li Zhu, Rui Chen, Hongbin Lv, Junjiang Fu
Identification of a novel heterozygous missense mutation in the CACNA1F gene in a chinese family with retinitis pigmentosa by next generation sequencing. BioMed research international 2015 (2015)

Junjiang Fu.css-eqlu8i{font-size:small;padding-left:4px;} (J Fu)

Publication Activity (10 Years)

Top Topics

Top Venues

Junjiang Fu (J Fu)